Mugwort Allergy: The One Pollen That Anchors Three Named Food Syndromes

Yes — mugwort pollen is the only allergen that anchors three named food cross-reactivity syndromes: celery-mugwort-spice syndrome, mugwort-mustard syndrome, and mugwort-peach association. These are driven by Art v 3, a non-specific lipid transfer protein (nsLTP) that cross-reacts with structurally similar proteins in celery, mustard, peach, apricot, and spices. Art v 3 is heat-stable and resistant to pepsin digestion, meaning mugwort food reactions can occur with cooked food. A study found that 48% of mugwort food-allergic patients had systemic reactions including anaphylaxis. If you have fall respiratory symptoms and have ever reacted to celery or mustard, mugwort testing should be part of your allergy workup. Component testing for Art v 3 versus Art v 4 is critical to determine your actual risk level.

Mugwort and ragweed are different species from the same Asteraceae family, and they share some molecular cross-reactivity — Art v 6 in mugwort is structurally homologous to Amb a 1, the dominant ragweed allergen. This means patients sensitized to ragweed may test weakly positive for mugwort and vice versa. However, they are clinically distinct: mugwort is the only one linked to the LTP food syndromes via Art v 3; ragweed has the broadest sensitization rate in the US at 15–20% of all Americans. The two species overlap in season and geography, making it easy to misattribute symptoms to the wrong allergen. Allergen-specific IgE testing for both Art v 1 and Amb a 1 is necessary to determine which allergen drives symptoms and to design a rational immunotherapy protocol.

The specific foods to avoid depend on which Art v allergen has sensitized you. If testing shows Art v 3 (nsLTP) positivity, you should discuss avoiding raw and cooked forms of celery, celeriac, carrot, parsley, fennel, anise, coriander, dill, mustard and mustard seeds, and stone fruits including peach, apricot, plum, and cherry. Art v 3 reactions are not eliminated by cooking and can cause anaphylaxis, so an epinephrine autoinjector is warranted for Art v 3-positive patients. If testing shows only Art v 4 (profilin) positivity, the same foods may cause mild oral allergy syndrome with raw forms but are typically safe when cooked. Working with an allergist to interpret component results is essential before making dietary decisions, as the avoidance lists look similar but carry very different risk levels.

Mugwort pollen season in the US runs July through September, with the peak in August. This overlaps substantially with ragweed season and the end of grass pollen season, creating a complex multi-allergen burden during late summer. Mugwort pollinates earlier than ragweed in most regions — if your symptoms start in July before ragweed's peak, mugwort may be the primary driver. Geographic variation exists: Pacific Northwest mugwort may peak slightly later than eastern US plants due to coastal climate moderation. Daily pollen count trackers that report Artemisia separately from total weed pollen are the most useful tools for confirming symptom-season correlation and adjusting medication timing accordingly.

Yes — allergen immunotherapy is effective for mugwort-driven respiratory allergy. Published clinical trials of both sublingual and subcutaneous immunotherapy for Artemisia vulgaris show statistically significant reductions in rhinitis symptom scores and antihistamine use compared to placebo, with cross-protection extending across the Artemisia genus. No FDA-approved sublingual tablet exists specifically for mugwort, so treatment requires custom formulations via allergist-prescribed subcutaneous injections or sublingual drops. Secondary benefits for food cross-reactivity have been reported in some studies, but Art v 3-sensitized patients with LTP-mediated food reactions should not use immunotherapy as a substitute for food avoidance and epinephrine access. The immunotherapy benefit is most robust for Art v 1-driven respiratory symptoms.

Mugwort (Artemisia vulgaris), wormwood (Artemisia absinthium), and sagebrush (Artemisia tridentata) are all members of the same Artemisia genus and share a complete cross-reactive allergen panel — meaning that patients sensitized to any one species typically react to all three. The practical difference is geographic and ecological: mugwort is the dominant Artemisia species in the eastern US and Europe, wormwood is found in disturbed roadsides and herbal gardens across the continent, and sagebrush is the dominant late-summer pollen source across the arid western US. All three share Art v 1 and Art v 3 allergen homologs. Immunotherapy for any one Artemisia species is expected to provide cross-protection against the others because the sensitizing proteins are structurally similar across the genus.

Yes — particularly if Art v 3 (nsLTP) is your primary sensitizing allergen rather than Art v 1. Art v 3-sensitized patients may present primarily with food reactions to celery, peach, or mustard year-round, without prominent seasonal rhinoconjunctivitis. This can lead to a workup focused on food allergy when the underlying driver is actually pollen sensitization. Conversely, Art v 1-sensitized patients with high IgE levels may experience heavy seasonal symptoms with little food cross-reactivity. Component testing helps clarify the clinical picture. Patients who present with unexplained food reactions to celery-family vegetables or stone fruits during any season should be screened for mugwort pollen sensitization as part of the diagnostic workup.

Mugwort respiratory allergy — driven by Art v 1 — is generally not dangerous, causing seasonal rhinoconjunctivitis and, in a minority of patients, mild-to-moderate asthma. However, Art v 3 (nsLTP) sensitization introduces genuine anaphylaxis risk from foods. A published study found that 48% of mugwort food-allergic patients experienced systemic reactions including anaphylaxis, primarily in Art v 3-sensitized individuals eating celery, peach, or mustard — including cooked forms of these foods. Patients with confirmed Art v 3 sensitization should carry a prescribed epinephrine autoinjector and wear medical identification. The key step is getting component-resolved testing to determine whether Art v 3 is part of your sensitization profile, which directly determines your risk level and management plan.

Celery-mugwort-spice syndrome is a named food-pollen cross-reactivity syndrome in which patients sensitized to mugwort pollen through respiratory exposure subsequently develop allergic reactions to celery, celeriac, and various spices including parsley, fennel, anise, coriander, and dill. The molecular mechanism involves Art v 3, an nsLTP in mugwort pollen that is structurally similar to LTP proteins in Apiaceae family plants. Unlike typical pollen-food syndrome driven by profilins (which cause mild oral symptoms eliminated by cooking), celery-mugwort-spice syndrome reactions can be systemic and can occur with cooked or processed foods because Art v 3 is heat-stable. This syndrome is particularly common in European populations and accounts for a substantial proportion of celery allergy diagnoses, many of which are actually mugwort-driven.

Whether you need an epinephrine autoinjector depends on your specific sensitization profile. If component testing shows Art v 3 (nsLTP) positivity, yes — Art v 3 sensitization places you at risk for systemic anaphylaxis from foods including cooked celery, mustard, and stone fruits, and an epinephrine autoinjector is the standard of care for that risk level. If your sensitization is limited to Art v 1 (the respiratory allergen) and Art v 4 (profilin, causing mild oral allergy syndrome), the anaphylaxis risk from food is much lower and an autoinjector may not be required. Mugwort pollen inhalation itself does not typically cause anaphylaxis. The decision should be made by an allergist after reviewing your component test results, clinical history of food reactions, and the severity of any prior systemic events.